NYSE

JOHNSON & JOHNSON (JNJ)

Company Overview

Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.

Contact Details

Address
ONE JOHNSON & JOHNSON PLZ
City
NEW BRUNSWICK
State
NJ
Country
USA
Zip Code
08933
Phone Number
732-524-0400
Website
-

Financial Highlights

Day Range

The price range a stock has traded at during the most recent trading period.

-
-
5 Day Range

The price range a stock has traded at during the previous 5 days.

-
-
3 Month Range

The price range a stock has traded at during the previous 3 months.

-
-
52 Week Range

The price range a stock has traded at during the previous 52 weeks.

-
-
Previous Close

The closing price of a stock from the previous day.

-
Open

The price of the stock at the start of today’s market opening.

-
Bid

The amount of money a trader is willing to pay per share for a given stock. 

x
-
Ask

The amount of money a seller wants per share of a given stock.

x
-
Volume

The number of shares traded in a given period. This number illustrates the active interest in the stock at any time.

-
Avg. Volume

The average number of shares traded in a given day.

-
Dividend Yield

A company's annual dividend expressed as a percentage of its current stock price.

-
Recent Dividend

The value a shareholder receives from a company they are invested in for holding their shares.

-
Beta

A measurement of the stock’s volatility in comparison to the market as a whole.

-

Shareholding

Shares Outstanding

Number of shares currently held by investors, including restricted shares owned by the company's officers and insiders.

-
Insider Shareholders

The percentage of shares owned by any officer or board director of the company, including their related or affiliated individuals, families, entities and trusts.

-
Institutional Shareholders

The percentage of shares owned by an institution such as a mutual fund, bank or insurance company.

-
Market Cap

The market value of a company’s outstanding shares. It is used as a measurement tool to determine how large a company is.

-
Revenue TTM

The amount of money a company has made for the trailing twelve-month period.

-
Net Income TTM

A measurement of how much profit they are retaining for the trailing twelve-month period.

-
P/E Ratio

The Price to Earnings (P/E) ratio, is calculated by dividing the stock's most recent share price by the sum of the diluted earnings per share.

-
EPS TTM

Earnings Per Share (EPS) TTM is a company's profit for the trailing twelve-month period divided by its number of common outstanding shares.

-
1 Year Return

A measurement of how much the stock has increased or decreased in the last year.

-

There is no stock data currently available for this time period, please select another option.

Please wait, gathering market data...

Latest News

View More
News |

The Dow just crossed 40,000 for the first time. The number is big but means little for your 401(k)

View More
News |

J&J subsidiary proposes paying about $6.48B over 25 years to settle talc ovarian cancer lawsuits

View More
News |

J&J to pump another $13B into its MedTech business with Shockwave deal

View More
News |

Amazon joins 29 other 'blue chip' companies in the Dow Jones Industrial Average

View More

Latest Analysis

View More
Latest Analysis |

Johnson & Johnson Proposes $6.48 Billion Settlement for Talc Lawsuits

View More
Johnson & Johnson logo on smartphone screen.
Latest Analysis |

Contineum Therapeutics Raises $110 Million in Successful IPO

View More
This image captures the essence of Contineum Therapeutics, Inc.'s debut on the NASDAQ Global Securities Market, highlighting its innovative spirit in the biotechnology industry and its successful IPO that raised $110 million.
Latest Analysis |

Johnson & Johnson (JNJ) Acquires Shockwave Medical (SWAV) for $13.1B

View More
heart health clipart image, designed in a wide format to emphasize the importance of cardiovascular wellness through lifestyle choices.
Latest Analysis |

Biopharmaceutical M&A Surge Revitalizes Industry

View More
The image showcases a handshake between two corporate leaders, symbolizing a partnership in the biopharmaceutical mergers and acquisitions sector. Generative AI.
Latest Analysis |

Is Investing in Shroom Stocks a Good Idea?

View More
Latest Analysis |

What is Life Sciences and Should You Invest?

View More